Clinical trial · Interventional
Intelligent Pain Management System for Assessing Pain in Cancer Patients
Development and Testing of an Intelligent Pain Management System (IPMS) for Chinese Patients With Cancer
NCT02765269CI-TRIAL-00024999completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether the Intelligent Pain Management System (IPMS) could make recording and interfering pain timely among cancer patients with pain. The system's usability, feasibility, compliance, and satisfaction will also be assessed.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intelligent Pain Management System | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- IPMS group
- description
- Cancer patients with pain are asked to use the Intelligent Pain Management System as much as possible to record the degree and location of pain at least once every day. Through assessments of these pain record, physicians could give the patients appropriate advice.
- interventionNames
- Device: Intelligent Pain Management System
- type
- NO_INTERVENTION
- label
- Control group
- description
- The control group are communicated through conventional method such as telephone calls or door-to-door visit to collect the pain assessment to guide doctors' therapy.
Primary outcomes (1)
- measure
- Feasibility of Mobile Application Assessed by Observing the Number of Daily Pain Assessments Recorded Among Patients
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 45 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * the patient was able to read Chinese and use smart phones; * the patient was diagnosed with cancer and has self-reported cancer pain within a month prior to the study; * the patient was being seen on a regular basis by the oncology team; * the patient was under standard analgesia treatments; * the patient was estimated to have over 3 months survival time. Exclusion Criteria: * the patients who self-reported to have severe cognitive impairments or major comorbid illnesses that would interfere with pain assessment.
References
Publications (1)
- DERIVEDSun Y, Jiang F, Gu JJ, Wang YK, Hua H, Li J, Cheng Z, Liao Z, Huang Q, Hu W, Ding G. Development and Testing of an Intelligent Pain Management System (IPMS) on Mobile Phones Through a Randomized Trial Among Chinese Cancer Patients: A New Approach in Cancer Pain Management. JMIR Mhealth Uhealth. 2017 Jul 25;5(7):e108. doi: 10.2196/mhealth.7178. PMID 28743681